España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
MannKind
MNKD
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$5.13
0.1
1.99%
At Close: -
$5.15
0.02
0.39%
After Hours: 5:02 PM EDT
15 minutes delayed
Get Report
Watch
MannKind (MNKD) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MannKind (NASDAQ:MNKD) Stock
MannKind Stock (NASDAQ: MNKD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, June 24, 2024
Reported Earlier, MannKind's Inhaled Insulin ...
Benzinga Newsdesk
Thursday, June 13, 2024
Rodman & Renshaw Initiates Coverage On MannKi...
Benzinga Newsdesk
Wednesday, May 29, 2024
Pulmatrix Enters Cross License Agreement With...
Benzinga Newsdesk
Thursday, May 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Wednesday, May 08, 2024
MannKind Q1 2024 Adj EPS $0.05 Beats $0.03 Es...
Benzinga Newsdesk
Monday, May 06, 2024
MannKind Announced The FDA Fast Track Designa...
Benzinga Newsdesk
Tuesday, April 30, 2024
MannKind Will Proceed With Phase 1 Nintedanib...
Benzinga Newsdesk
Monday, April 29, 2024
MannKind shares are trading higher after the ...
Benzinga Newsdesk
MannKind Announces IND Clearance From US FDA ...
Benzinga Newsdesk
Wednesday, April 03, 2024
MannKind Announced That It Has Repaid In Full...
Benzinga Newsdesk
Tuesday, March 26, 2024
MannKind Appoints Christopher Prentiss As CFO...
Benzinga Newsdesk
Friday, March 15, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Monday, March 11, 2024
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
Avi Kapoor
What's Going On With MannKind Stock?
Erica Kollmann
MannKind Announced Initial Meal Challenge Dat...
Benzinga Newsdesk
Friday, March 08, 2024
Cramer Says Sprout Social Is In A 'Hot Spot,' But This Energy Stock Is 'Too Down And Out'
Avi Kapoor
Tuesday, March 05, 2024
MannKind Announced That New Clinical Data Fro...
Benzinga Newsdesk
Wednesday, February 28, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Tuesday, February 27, 2024
MannKind Q4 2023 Adj EPS $0.02 Beats undefine...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
MannKind Earnings Preview
Benzinga Insights
Thursday, February 15, 2024
MannKind Has Enrolled 305 Patients With Type ...
Benzinga Newsdesk
Thursday, January 04, 2024
HC Wainwright & Co. Reiterates Buy on MannKin...
Benzinga Newsdesk
Tuesday, January 02, 2024
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
MannKind shares are trading higher after the ...
Benzinga Newsdesk
MannKind Sold A 1% Royalty In Net Sales Of Ty...
Benzinga Newsdesk
Wednesday, December 27, 2023
MannKind Entered Into Seventh Amendment To Su...
Benzinga Newsdesk
Wednesday, December 20, 2023
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Tuesday, November 07, 2023
Recap: MannKind Q3 Earnings
Benzinga Insights
MannKind Q3 2023 Adj EPS $0.01 Beats $(0.02) ...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
A Preview Of MannKind's Earnings
Benzinga Insights
MannKind Completes Enrollment in US Phase 4 I...
Benzinga Newsdesk
Monday, October 30, 2023
Mannkind Announced A New US Patent Covering C...
Benzinga Newsdesk
Tuesday, October 10, 2023
MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback'
Priya Nigam
MannKind shares are trading higher after Wedb...
Benzinga Newsdesk
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Benzinga Insights
Wedbush Initiates Coverage On MannKind with O...
Benzinga Newsdesk
Monday, August 14, 2023
Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday
Lisa Levin
HC Wainwright & Co. Maintains Buy on MannKind...
Benzinga Newsdesk
Tuesday, August 08, 2023
Cantor Fitzgerald Maintains Overweight on Man...
Benzinga Newsdesk
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Monday, August 07, 2023
UPDATE: MannKind Q2 Adj. EPS $0.00 Beats $(0.04) Estimate, Sales $48.61M Beat $42.03M Estimate
Happy Mohamed
MannKind Q2 Adj. EPS $0.00 Beats $(0.04) Esti...
Benzinga Newsdesk
Earnings Scheduled For August 7, 2023
Benzinga Insights
Friday, August 04, 2023
Earnings Preview For MannKind
Benzinga Insights
Monday, July 03, 2023
Mannkind Said On June 26, Was Informed Co's Contract Manufacturer Of Clofazimine Inhalation Solution Experienced Fire In Its Manufacturing Unit, Germany; Co Estimates Production Of Clinical Supplies Of MNKD-101 Will Be Delayed By 3-6 Months
Charles Gross
Thursday, June 22, 2023
Mannkind Has Launched INHALE-3 Study In Type ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
